Small but seasoned DMI Research is a long-standing multi-therapeutic clinical trial site with 25+ years in operation and a tight team of 11-50 employees. This suggests stability and specialized expertise that can be leveraged to compete for multi-site Phase I-IV trials and partner networks seeking experienced sites with proven regulatory knowledge.

Broad trial reach Capabilities include multi-specialty Phase I-IV trials, 300+ completed studies, CLIA licensure, and access to a large patient database. This positions DMI as a capable partner for sponsors needing diverse therapeutic coverage and rapid enrollment across Pinellas County and the Tampa Bay area.

Robust operations Experience with multiple EDC IWRS/IVRS platforms, GCP and IATA trained staff, IV and sterile drug prep, secure climate-controlled drug storage with digital temperature monitoring. These capabilities reduce sponsor risk and streamline trial execution and data integrity.

Localization edge Strategic regional footprint around Pinellas County and Tampa Bay, with bilingual recruitment and staff. This enables effective patient engagement, faster enrollment, and potential to serve regional studies or trials requiring local population access.

Growth opportunities Potential sales angles include expanding participation in pharmacokinetic safety labs and niche areas like women’s and men’s health, leveraging private monitoring space and remote monitoring capabilities to attract sponsors prioritizing remote/central monitoring and enhanced patient safety.